Daprodustat (Jesduvroq) for anemia of chronic kidney disease
- PMID: 38412265
- DOI: 10.58347/tml.2024.1696a
Daprodustat (Jesduvroq) for anemia of chronic kidney disease
Keywords: Aranesp; Epogen; Jesduvroq; Mircera; Procrit; Retacrit; adverse effects; anemia; chronic kidney disease; daprodustat; darbepoetin alfa; dosage; drug interactions; efficacy; epoetin alfa; iron; lactation; pregnancy; safety.
Similar articles
-
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia: A Randomized, Double-Blind, Phase 3 Trial.Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1155-1165. doi: 10.2215/CJN.16011219. Epub 2020 Jul 28. Clin J Am Soc Nephrol. 2020. PMID: 32723804 Free PMC article. Clinical Trial.
-
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.JAMA Intern Med. 2022 Jun 1;182(6):592-602. doi: 10.1001/jamainternmed.2022.0605. JAMA Intern Med. 2022. PMID: 35377393 Free PMC article. Clinical Trial.
-
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.N Engl J Med. 2021 Dec 16;385(25):2313-2324. doi: 10.1056/NEJMoa2113380. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739196 Clinical Trial.
-
An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat.Adv Ther. 2018 Jan;35(1):5-11. doi: 10.1007/s12325-017-0655-z. Epub 2017 Dec 28. Adv Ther. 2018. PMID: 29285707 Free PMC article. Review.
-
Effect of daprodustat on anemia in patients with chronic kidney disease: a meta-analysis.Int Urol Nephrol. 2018 Dec;50(12):2201-2206. doi: 10.1007/s11255-018-1940-8. Epub 2018 Aug 2. Int Urol Nephrol. 2018. PMID: 30073615 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical